Alkem Laboratories Ltd.

₹5,722.5

-31.5 (-0.5%)

ALKEM Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 68,391 Cr

P/E Ratio31.59

Dividend Yield0.39 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	5,728.4	Bearish
10-DMA	5,764.1	Bearish
20-DMA	5,707.3	Bullish
50-DMA	5,666.97	Bullish
100-DMA	5,588.21	Bullish
200-DMA	5,310.76	Bullish

Historical Performance

1 Year

16.4%

3 Years

90.7%

5 Years

87.5%

10 Years

323.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,29,645	1,26,676	1,15,993	1,06,342	88,650
Total Expenditure	1,04,524	1,04,221	99,898	85,813	69,226
Other Income	4,937	3,108	2,161	1,626	2,332
Operating Profit	30,059	25,563	18,255	22,156	21,756
Interest	1,217	1,124	1,074	524	589
Depreciation	3,572	2,993	3,104	3,040	2,746
Profit Before Tax	25,270	20,231	13,048	18,443	18,421
Consolidated Net Profit	21,655	17,958	9,842	16,456	15,850
Adjusted EPS	181	150	82	138	133

Compounded Sales Growth

10 Years:28.2

5 Years:9.2

3 Years:4

TTM:0.5

Compounded Profit Growth

10 Years:40.8

5 Years:14

3 Years:5.6

TTM:3.8

Stock Price CAGR

10 Years:15.5

5 Years:13.7

3 Years:24

TTM:14.4

Return on Equity

10 Years:62

5 Years:132.6

3 Years:82.3

last year:181.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	239	239	239	239	239
Total Reserves	1,19,248	1,02,686	90,208	86,134	73,517
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-4,458	-6,489	-6,880	-8,927	-7,507
Other Current Liabilities	11,642	8,919	8,388	7,714	6,431
Short Term Borrowings	7,349	11,726	13,071	25,706	16,360
Total Liabilities	1,59,528	1,40,601	1,24,542	1,27,599	1,04,114
Capital Work in Progress	4,766	1,484	3,103	3,395	3,933
Long Term Loans & Advances	5,082	2,037	1,391	1,544	938
Currents Investments	9,023	1,490	3,172	1,393	1,788
Short Term Loans and Advances	28,009	35,321	6,879	5,859	5,047
Total Current Assets	1,08,112	1,04,116	86,064	84,337	69,233
Total Assets	1,59,528	1,40,601	1,24,542	1,27,599	1,04,114
Adjusted Book Value	999	861	757	722	617

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 31.59, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 24.0%, indicating sustained price appreciation.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹30059 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹129645 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1143516.6

No. of Shares: 200 (Approx)

Performance:14.4%

P/L: ₹143516.6

NIFTY Performance: 9.4%

1 day Top Gainers